Biofrontera Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 97.84%37.57%48.80%50.14%
EBT Margin -156.25%-2.12%-59.04%-47.53%
EBIT Margin -104.57%-64.80%-66.56%-46.11%
EBITDA Margin -104.57%-64.80%-66.56%-46.11%
Operating Margin -104.57%-64.80%-66.56%-46.11%
Net Margin -156.49%-2.23%-59.09%-47.58%
FCF Margin -110.90%-56.63%-73.10%-27.63%
Efficiency
Inventory Average 5.77M5.81M9.04M8.78M
Assets Average 38.68M52.05M39.41M25.02M
Equity Average 8.58M17.61M14.34M4.61M
Invested Capital 5.83M14.58M30.82M8.70M4.43M
Asset Utilization Ratio 0.620.550.861.49
Leverage & Solvency
Interest Coverage Ratio -103.08-8.17
Debt to Equity 0.290.290.81
Debt Ratio 0.060.140.14
Equity Ratio 0.240.210.470.170.20
Times Interest Earned -103.08-8.17
Valuation
Enterprise Value -8.10M88.68M-3.28M2.78M2.53M
Market Capitalization 113.22M24.47M4.20M8.45M
Return Ratios
Return on Sales -1.56%-0.02%-0.59%-0.48%
Return on Capital Employed -1.01%-0.60%-1.06%-1.32%
Return on Assets -0.98%-0.01%-0.51%-0.71%
Return on Equity -4.39%-0.04%-1.40%-3.85%